To assess the benefits and harms of clevudine versus placebo, no intervention, or any of the nucleoside/nucleotide analogues, in people with chronic HBV infection.
This is a protocol.
Clevudine in people with chronic hepatitis B virus infection
You may also be interested in:
- Interferon for people with lamivudine-resistant chronic hepatitis B virus infection
- Glycyrrhizin for chronic hepatitis B virus infection
- Adefovir dipivoxil for adults with lamivudine-resistant chronic hepatitis B virus infection
- Entecavir for patients with lamivudine-resistant chronic hepatitis B virus infection
- Emtricitabine for adults with lamivudine-resistant chronic hepatitis B virus infection
Health topics: